5 Insightful Analyst Questions From IDEX’s Q2 Earnings Call

via StockStory
ⓘ This article is third-party content and does not represent the views of this site. We make no guarantees regarding its accuracy or completeness.

IEX Cover Image

IDEX’s latest quarter was marked by solid performance, as the company exceeded Wall Street’s revenue and earnings estimates, prompting a positive market reaction. Management attributed these results to higher volumes from its growth platforms, particularly within the Health & Science Technologies (HST) segment, fueled by demand in data center, semiconductor, and space and defense end markets. CEO Eric Ashleman highlighted that “orders came in better than expected, growing 28% organically,” with HST organic order growth at 47%. The company also benefited modestly from U.S. tariff refunds, which provided some margin and earnings tailwind, but the underlying strength was driven by operational execution and robust demand across key markets.

Is now the time to buy IEX? Find out in our full research report (it’s free for active Edge members).

IDEX (IEX) Q2 CY2026 Highlights:

  • Revenue: $920.6 million vs analyst estimates of $905.4 million (6.4% year-on-year growth, 1.7% beat)
  • Adjusted EPS: $2.32 vs analyst estimates of $2.11 (10.1% beat)
  • Adjusted EBITDA: $258.3 million vs analyst estimates of $242.3 million (28.1% margin, 6.6% beat)
  • Revenue Guidance for Q3 CY2026 is $931.4 million at the midpoint, above analyst estimates of $912.2 million
  • Management raised its full-year Adjusted EPS guidance to $8.77 at the midpoint, a 3.8% increase
  • Operating Margin: 21.7%, in line with the same quarter last year
  • Organic Revenue rose 5% year on year (miss)
  • Market Capitalization: $17.54 billion

While we enjoy listening to the management’s commentary, our favorite part of earnings calls is the analyst questions. Those are unscripted and can often highlight topics that management teams would rather avoid or topics where the answer is complicated. Here is what has caught our attention.

Our Top 5 Analyst Questions From IDEX’s Q2 Earnings Call

  • Michael Halloran (Baird) asked about sequential improvement in traditional short-cycle businesses and order visibility. CEO Eric Ashleman said both direct OEM and distributor channel orders are showing encouraging signs, with backlog visibility now extending further into the future, especially for data center projects.
  • Bryan Blair (Oppenheimer) pressed for detail on the sustainability of double-digit growth in Intelligent Water. Ashleman explained the business is benefiting from both municipal wastewater analytics and high-purity pumps for semiconductor applications and sees no signs of near-term slowdown.
  • Joseph Giordano (TD Cowen) asked how much of the growth is attributable to strategic platform shifts versus general market trends. Ashleman stressed that IDEX’s unique component solutions and innovation, especially through acquisitions, are distinct contributors beyond simple market tailwinds.
  • Nathan Jones (Stifel) questioned the rationale for increased capital expenditures. Ashleman clarified these investments are targeted at HST businesses with multiyear visibility, not for alleviating current bottlenecks, and are expected to support future growth without increasing overall asset intensity.
  • Andrew Buscaglia (BNP Paribas) inquired about the sustainability of high margins in the Fluid & Metering Technologies segment if volumes recover. CFO Sean Gillen replied that volume growth would drive significant incremental margin flow-through, potentially approaching 40%.

Catalysts in Upcoming Quarters

In coming quarters, our team is watching (1) the pace at which demand in technology end markets continues to translate into sustained organic revenue growth, (2) margin performance as IDEX increases investment in capacity and integrates recent acquisitions, and (3) the resilience of traditional industrial and distributor-driven order flows amid macroeconomic uncertainty. Progress on capital deployment priorities and new product rollouts will also serve as important signposts for execution.

IDEX currently trades at $237.84, up from $224.65 just before the earnings. In the wake of this quarter, is it a buy or sell? Find out in our full research report (it’s free).

Our Favorite Stocks Right Now

ALSO WORTH WATCHING: Top 5 Momentum Stocks. The best time to own a great stock is when the market is finally noticing it. These aren’t just high-quality businesses. Something is happening with them right now. Elite fundamentals meet near-term momentum — both boxes checked at the same time.

Find out which stocks our AI platform is flagging this week. See this week’s Strong Momentum stocks — FREE. Get Our Strong Momentum Stocks for Free HERE.

Stocks that have made our list include now familiar names such as Nvidia (+1,460% between June 2020 and June 2025) as well as under-the-radar businesses like the once-micro-cap company Tecnoglass (+1,552% between June 2020 and June 2025). Find your next big winner with StockStory today.

Report this content

If you believe this article contains misleading, harmful, or spam content, please let us know.

Report this article